Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
- 20 January 2021
- journal article
- research article
- Published by Elsevier BV in Biosensors and Bioelectronics
- Vol. 178, 113008
- https://doi.org/10.1016/j.bios.2021.113008
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 29 references indexed in Scilit:
- Risk factors for severity and mortality in adult COVID-19 inpatients in WuhanJournal of Allergy and Clinical Immunology, 2020
- Clinical Performance of Two SARS-CoV-2 Serologic AssaysClinical Chemistry, 2020
- Dissecting antibody-mediated protection against SARS-CoV-2Nature Reviews Immunology, 2020
- Human neutralizing antibodies elicited by SARS-CoV-2 infectionNature, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020